Related Experiment Video
Updated: Aug 20, 2025

Mouse Adipose Tissue Collection and Processing for RNA Analysis
Published on: January 31, 2018
Serum adiponectin levels and adiponectin +276 G/T gene polymorphism in newborns with large and small birth weights
Emine Esin Yalinbas1, Raziye Akcilar2
1Department of Neonatology, Eskisehir City Hospital, Eskisehir, Turkey.
Insights
The adiponectin +276 G/T gene polymorphism is linked to newborn size, with specific genotypes increasing the risk of being small for gestational age (SGA). Serum adiponectin levels correlate with birth measurements, suggesting adiponectin's role in fetal growth.
Area of Science:
- Genetics and Molecular Biology
- Neonatology
- Endocrinology
Background:
- Adiponectin plays a crucial role in regulating fetal and neonatal growth through its influence on metabolism, energy balance, and insulin sensitivity.
- Understanding the genetic factors influencing adiponectin levels and their impact on birth size is essential for neonatal health research.
Purpose of the Study:
- To investigate the association between the adiponectin +276 G/T gene polymorphism and serum adiponectin levels in newborns.
- To determine if this polymorphism correlates with birth size categories: appropriate for gestational age (AGA), small for gestational age (SGA), or large for gestational age (LGA).
Main Methods:
- Genotyping for the adiponectin +276 G/T polymorphism was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
- Serum adiponectin levels were quantified using enzyme-linked immunosorbent assay (ELISA).
- Newborns were categorized into AGA, SGA, and LGA groups (n=65 each).
Main Results:
- SGA newborns exhibited significantly lower serum adiponectin levels compared to AGA and LGA newborns.
- Significant differences in genotype frequencies (GG, GT, TT) were observed across SGA, AGA, and LGA groups (chi-square = 15.8, p=0.003).
- Carrying the GT genotype was associated with an increased risk of being SGA (OR=3.07, p=0.005 for GG; OR=6.96, p<0.001 for TT), while GG and TT genotypes offered protection against SGA.
- Newborns with the GT genotype had lower birth weights and head circumferences compared to those with the TT genotype (p<0.001).
- Serum adiponectin levels did not significantly differ across adiponectin +276 G/T genotypes (p=0.429) but showed a positive correlation with birth weight, length, head circumference, and ponderal index.
Conclusions:
- The adiponectin +276 G/T gene polymorphism is associated with variations in newborn birth size, influencing the likelihood of being SGA or LGA.
- The impact of this polymorphism on neonatal size appears to be independently linked to serum adiponectin levels.
- Adiponectin likely plays a significant role in fetal growth regulation.
Purpose:
Adiponectin may be an important indicator in the regulation of fetal and neonatal growth due to its metabolism, energy balance, and insulin-sensitizing action. The current study's goal was to determine if there is a link between adiponectin +276 G/T gene polymorphism and serum adiponectin level in newborns classified as appropriate for gestational age (AGA), small for gestational age (SGA), or large for gestational age (LGA).
Methods:
The study included newborns classified as AGA (n = 65), SGA (n = 65), or LGA (n = 65) according to their gestational age or birth weight. To determine the presence of adiponectin +276 G/T gene polymorphism, genotyping was done using polymerase chain reaction-restriction fragment length polymorphism. Enzyme-linked immunosorbent assay was used to determine the level of adiponectin in the blood.
Results:
The SGA newborns had significantly lower levels of serum adiponectin than the AGA and LGA newborns. There were statistically significant differences between the genotype frequencies (GG, GT, TT) of the SGA newborns (29.9%, 45.1%, 13.9%), the AGA newborns (41.6%, 20.7%, 44.4%), and the LGA newborns (28.6%, 34.1%, 41.7%) (chi-square = 15.8; degree of freedom = 4; p = .003). The newborns carrying the GT genotype had an increased risk of being SGA compared to those carrying the GG and TT genotypes (odds ratio [OR] = 3.07; confidence interval [CI] = 95% (1.38-6.64); p = .005 and OR = 6.96; CI = 95% (2.19-22.1); p < .001, respectively). The newborns carrying the GG and TT genotypes had better protection against being SGA than those carrying the GT genotype (OR = 0.33; CI = 95% (0.15-0.72); p = .005 and OR = 0.14; CI = 95% (0.05-0.46); p < .001, respectively). The newborns carrying the GT genotype had lower birth weights, head circumferences, and ponderal indices than those carrying the TT genotype (p < .001). The serum adiponectin levels between adiponectin +276 G/T genotypes did not differ significantly (p = .429). In addition, serum adiponectin level showed a significant positive correlation with birth weight, birth length, head circumference, and ponderal index in all newborns.
Conclusion:
The results of the current study suggest that the adiponectin +276 G/T gene polymorphism was associated with an increased chance of being born SGA or LGA. The effect of this polymorphism on newborn birth size was independently associated with serum adiponectin levels. Adiponectin may play a role in fetal growth.
More Related Videos
Related Concept Videos
Polygenic Traits
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

